Document Detail

Botanical-Drug Interactions: A Scientific Perspective.
MedLine Citation:
PMID:  22864989     Owner:  NLM     Status:  Publisher    
There is a continued predisposition of concurrent use of drugs and botanical products. A general lack of knowledge of the interaction potential together with an under-reporting of botanical use poses a challenge for the health care providers and a safety concern for patients. Botanical-drug interactions increase the patient risk, especially with regard to drugs with a narrow therapeutic index (e.g., warfarin, cyclosporine, and digoxin). Examples of case reports and clinical studies evaluating botanical-drug interactions of commonly used botanicals in the US are presented. The potential pharmacokinetic and pharmacodynamic bases of such interactions are discussed, as well as the challenges associated with the interpretation of the available data and prediction of botanical-drug interactions. Recent FDA experiences with botanical products and interactions including labeling implications as a risk management strategy are highlighted.
Manuela de Lima Toccafondo Vieira; Shiew-Mei Huang
Related Documents :
17639749 - Secondary hypertension due to drugs and toxins.
22321259 - Medications in patients treated with therapeutic plasma exchange: prescription dosage, ...
11444579 - Patient-reported adherence to guidelines of the sixth joint national committee on preve...
22654399 - Chronopharmacognosy.
22815099 - Competition in prescription drug markets: the roles of trademarks, advertising, and gen...
12716139 - Treatments and strategies to optimize the comprehensive management of patients with pul...
24675279 - Doxorubicin-conjugated core-shell magnetite nanoparticles as dual-targeting carriers fo...
23319329 - Stevens johnson syndrome-an adverse drug reaction occurred after uncomplicated removal ...
8285619 - Toxoplasma gondii: susceptibility and development of resistance to anticoccidial drugs ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-8-3
Journal Detail:
Title:  Planta medica     Volume:  -     ISSN:  1439-0221     ISO Abbreviation:  Planta Med.     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-8-6     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0066751     Medline TA:  Planta Med     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Georg Thieme Verlag KG Stuttgart · New York.
Office of Clinical Pharmacology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  In Vitro Acanthamoebicidal Activity of Fusaric Acid and Dehydrofusaric Acid from an Endophytic Fungu...
Next Document:  A study on the effects of lead, cadmium and phosphorus on the lead and cadmium uptake efficacy of Vi...